Viet Nam STOP-TB Partnership: Building a Sustainable Response 1 Nguyen Dinh Huong , Dinh Ngoc Sy2 Nguyen Viet Nhung2, Nguyen Ngoc Minh2 Bruce Struminger3, Cornelia Hennig4 November 15, 2012 Kuala Lumpur, Malaysia 1. Chair of VSTP 3. Former Co-Chair VSTP 2. Vietnam NTP 4. Co Chair VSTP Vietnam STOP-TB Partnership: Outline 1. Country background information 2. TB epidemiology 3. Challenges 4. National partnership introduction 5. Partnership principal activities 6. Conclusion 1. Country Background Information • Area: 330.957 km2 • Distance: >3.200km, borders with China, Laos & Cambodia • Population: 89 million (2011) • Rural: 59,952 million (68,25%) • Urban: 27,888 million (31,75%) • Average density: 265/km2 • Administration • Provinces: 63 • Districts: 698 • Communes: 11,121 • LLMI country since 2010: $1,411 GDP per capita (2011) 2. TB epidemiology in Viet Nam • Ranks 12th among 22 TB high burden countries. • Ranks 14th among 27 countries with high burden of MDR-TB. • TB prevalence in Viet Nam remains high. National prevalence survey (VINCOTB-06) showed that the previous estimation was 40% ? underestimated by 60%. Too difficult, … A significant number (~40%) of tuberculosis cases remain undiagnosed or unreported. TB epidemiology in Viet Nam 2006 ( WHO Report - 2008) Incidence all cases /100.000 173 Incidence new AFB (+) /100.000 77 114 (Prevalence new AFB (+) -VINCOTB-06) Prevalence all cases/100,000 225 Prevalence AFB (+) /100.000 90 145 VINCOTB-06 TB mortality /100.000 23 Of new TB cases, % HIV (+) 5.0% Of new TB cases, % MDR-TB 2.7% Of previous treated TB, % MDR-TB 19% TB case notification Notification trend 2000-10, Viet Nam Number of suspect screened 2000-09, Viet Nam 800 000 20 s e s 600 000 a c y s+ vit /s 400 000 10siti s o ct p e # suspects % p s # ss+ TB cases u 200 000 s %positivity # 0 0 1 2 3 4 5 6 7 8 9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 NTP End term Evaluation 2007-2011. 2 2 2 2 2 2 2 2 2 2 3. TB Response Challenges: human and financial resource, programmatic • Human resources – Stigma, low financial compensation, and perceived risk affect recruitment; lack of sufficient staff results in over- work; in combination these result in high staff turn-over – Need for training on new approaches and techniques • Financial resources – GVN budget: grossly insufficient, barely covering DOTS – Heavy dependence on external funding for PMDT, TB/HIV, PPM, ACSM, high risk groups in context of rapidly decreasing funding – New diagnostic tools: promising but expensive Funding levels & gaps, 2013-15 (1) Financial Need (USD) 2013 2,014 2,015 Total Objective 1: High quality DOTS 48,557,537 54,067,373 49,350,967 151,975,876 Objective 2: TB/HIV, MDR-TB, 6,449,221 7,254,870 8,267,339 21,971,429 Closed settings Objective 3: HSS 3,445,845 4,310,847 4,487,344 12,244,036 Objective 4: PPM 2,814,085 2,164,900 2,154,153 7,133,138 Objective 5: ACSM 4927475 4934582 4633739 14,495,796 Objective 6: Surveillance and 393,000 1,577,764 435,000 2,405,764 research Total (in US$s) 66,587,162 74,310,335 69,328,542 210,226,039 Funding levels & gaps, 2013-15 (2) Financial Gap (USD) 2013 2014 2015 Total Funding needs 2011- 66,587,162 74,310,335 69,328,542 210,226,039 2015 Estimated fund Central Gov’t budget 5,500,000 6,000,000 6,500,000 18,000,000 Provincial Gov Fund 4,741,607 5,435,115 6,152,621 16,329,343 Global Fund 10,503,688 10,616,383 11,495,842 32,615,913 TB CARE I (PEPFAR) 3,900,171 3,900,171 3,900,171 9,600,342 EXPAND TB In-kind n/a n/a CDC (PEPFAR) 293,000 293,000 293,000 879,000 Total in US $s 24,938,466 26,244,669 28,341,634 79,524,769 Funding Gap, US $s 41,648,696 48,065,666 40,986,908 130,701,270 Programmatic challenges Challenge Intervention Ss(-) & EPTB increase HIV/TB Relapse/failure/default cases & reTx after default DOT / PMDT increase High CNR + poor Tx outcomes in congregate TB control in settings congregate settings High Tx success rate, but high prevalence rate and + PPM ~40% incident cases untreated each year Very low CNR among children less than 14 years Childhood TB control Strengthening of recording/reporting
Description: